Kimberly P. Briley

1.5k total citations · 1 hit paper
28 papers, 1.2k citations indexed

About

Kimberly P. Briley is a scholar working on Transplantation, Nephrology and Surgery. According to data from OpenAlex, Kimberly P. Briley has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Transplantation, 10 papers in Nephrology and 7 papers in Surgery. Recurrent topics in Kimberly P. Briley's work include Renal Transplantation Outcomes and Treatments (16 papers), Renal Diseases and Glomerulopathies (10 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Kimberly P. Briley is often cited by papers focused on Renal Transplantation Outcomes and Treatments (16 papers), Renal Diseases and Glomerulopathies (10 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Kimberly P. Briley collaborates with scholars based in United States. Kimberly P. Briley's co-authors include Lorita M. Rebellato, Carl E. Haisch, Paul G. Catrou, Paul I. Terasaki, Paul Bolin, Scott A. Kendrick, William T. Kendrick, Matthew J. Everly, Robert C. Harland and Miyuki Ozawa and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Clinical Chemistry.

In The Last Decade

Kimberly P. Briley

26 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts

2013 292 citations Matthew J. Everly, Lorita M. Rebellato et al. Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kimberly P. Briley United States	15	935	552	339	305	117	28	1.2k
Amit Govil United States	17	901 1.0×	549 1.0×	348 1.0×	315 1.0×	156 1.3×	50	1.4k
Scott A. Kendrick United States	10	697 0.7×	403 0.7×	258 0.8×	258 0.8×	85 0.7×	12	886
Sakarn Bunnag Thailand	10	806 0.9×	500 0.9×	243 0.7×	319 1.0×	125 1.1×	16	1.1k
Scott Ames United States	17	522 0.6×	500 0.9×	385 1.1×	217 0.7×	254 2.2×	33	1.3k
Meritxell Ibernón Spain	20	631 0.7×	363 0.7×	136 0.4×	333 1.1×	102 0.9×	39	1.1k
Miguel Hueso Spain	20	883 0.9×	593 1.1×	125 0.4×	290 1.0×	139 1.2×	61	1.4k
H. H. Neumayer Germany	21	652 0.7×	365 0.7×	152 0.4×	207 0.7×	305 2.6×	54	1.4k
Bert L Kasiske United States	9	559 0.6×	363 0.7×	111 0.3×	199 0.7×	91 0.8×	11	755
Joshua Miller United States	12	1.4k 1.5×	762 1.4×	169 0.5×	112 0.4×	270 2.3×	19	1.7k
Hemangshu Podder United States	14	606 0.6×	459 0.8×	120 0.4×	87 0.3×	98 0.8×	37	910

Countries citing papers authored by Kimberly P. Briley

Since Specialization

Citations

This map shows the geographic impact of Kimberly P. Briley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly P. Briley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly P. Briley more than expected).

Fields of papers citing papers by Kimberly P. Briley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly P. Briley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly P. Briley. The network helps show where Kimberly P. Briley may publish in the future.

Co-authorship network of co-authors of Kimberly P. Briley

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly P. Briley. A scholar is included among the top collaborators of Kimberly P. Briley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly P. Briley. Kimberly P. Briley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fallon, John T., et al.. (2024). Wastewater based epidemiology as a surveillance tool during the current COVID-19 pandemic on a college campus (East Carolina University) and its accuracy in predicting SARS-CoV-2 outbreaks in dormitories. PLoS ONE. 19(4). e0289906–e0289906. 2 indexed citations

Huang, Weihua, et al.. (2024). Local Genomic Surveillance of Invasive Streptococcus pyogenes in Eastern North Carolina (ENC) in 2022–2023. International Journal of Molecular Sciences. 25(15). 8179–8179. 3 indexed citations

Huang, Weihua, et al.. (2023). Dynamic Evolution of SARS-CoV-2 in a Patient on Chemotherapy. Viruses. 15(8). 1759–1759.

Briley, Kimberly P., et al.. (2022). Post‐kidney transplant cancers: Racial and ethnic differences in sun‐exposed skin versus non‐sun‐exposed anogenital skin. Cancer Medicine. 12(6). 7348–7355. 1 indexed citations

Rebellato, Lorita M., Kimberly P. Briley, Paul Bolin, et al.. (2016). Incidence and impact of anti‐HLA‐DP antibodies in renal transplantation. Clinical Transplantation. 30(9). 1108–1114. 19 indexed citations

Everly, Matthew J., Lorita M. Rebellato, Carl E. Haisch, et al.. (2014). Impact of IgM and IgG3 Anti-HLA Alloantibodies in Primary Renal Allograft Recipients. Transplantation. 97(5). 494–501. 58 indexed citations

Everly, Matthew J., Lorita M. Rebellato, Carl E. Haisch, et al.. (2014). Changes in Successive Measures of De Novo Donor-Specific Anti–Human Leukocyte Antigen Antibodies Intensity and The Development of Allograft Dysfunction. Transplantation. 98(10). 1097–1104. 13 indexed citations

Rebellato, Lorita M., Karen Parker, Matthew J. Everly, et al.. (2014). Improved Long-Term Survival in Kidney Transplant Recipients with Donor-Specific HLA Antibodies After Mycophenolic Acid Escalation.. PubMed. 137–42. 2 indexed citations

Rebellato, Lorita M., Junchao Cai, Kimberly P. Briley, et al.. (2013). Higher Risk of Kidney Graft Failure in the Presence of Anti-Angiotensin II Type-1 Receptor Antibodies. American Journal of Transplantation. 13(10). 2577–2589. 167 indexed citations

10.

Everly, Matthew J., Lorita M. Rebellato, Carl E. Haisch, et al.. (2013). Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts. Transplantation. 95(3). 410–417. 292 indexed citations breakdown →

11.

Wu, Pingping, Matthew J. Everly, Lorita M. Rebellato, et al.. (2013). Trends and Characteristics in Early Glomerular Filtration Rate Decline After Posttransplantation Alloantibody Appearance. Transplantation. 96(10). 919–925. 10 indexed citations

12.

Rebellato, Lorita M., Carl E. Haisch, Miyuki Ozawa, et al.. (2011). A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients.. PubMed. 337–40. 9 indexed citations

13.

Everly, Matthew J., Lorita M. Rebellato, Mikki Ozawa, et al.. (2010). Beyond Histology: Lowering Human Leukocyte Antigen Antibody to Improve Renal Allograft Survival in Acute Rejection. Transplantation. 89(8). 962–967. 47 indexed citations

14.

Mao, Qiuxia, Junchao Cai, Kimberly P. Briley, et al.. (2007). Extremely High Association Between Appearance of HLA Antibodies and Failure of Kidney Grafts in a Five-Year Longitudinal Study. American Journal of Transplantation. 7(4). 864–871. 175 indexed citations

15.

Kazmierczak, Steven C., Alex Robertson, Kimberly P. Briley, Bill L. Kreamer, & Glenn R. Gourley. (2004). Transcutaneous Measurement of Bilirubin in Newborns: Comparison with an Automated Jendrassik–Grof Procedure and HPLC. Clinical Chemistry. 50(2). 433–435. 21 indexed citations

16.

Kazmierczak, Steven C., Alex Robertson, & Kimberly P. Briley. (2002). Comparison of Hemolysis in Blood Samples Collected Using an Automatic Incision Device and a Manual Lance. Archives of Pediatrics and Adolescent Medicine. 156(11). 1072–1072. 19 indexed citations

17.

Kazmierczak, Steven C., Alex Robertson, Paul G. Catrou, et al.. (2002). Direct Spectrophotometric Method for Measurement of Bilirubin in Newborns: Comparison with HPLC and an Automated Diazo Method. Clinical Chemistry. 48(7). 1096–1097. 60 indexed citations

18.

Kazmierczak, Steven C., Paul G. Catrou, & Kimberly P. Briley. (2000). Transient Nature of Interference Effects from Heterophile Antibodies: Examples of Interference with Cardiac Marker Measurements. Clinical Chemistry and Laboratory Medicine (CCLM). 38(1). 33–39. 27 indexed citations

19.

Kazmierczak, Steven C., et al.. (1999). Multiple Regression Analysis of Interference Effects from a Hemoglobin-Based Oxygen Carrier Solution. Clinical Chemistry and Laboratory Medicine (CCLM). 37(4). 453–464. 12 indexed citations

20.

Gemperline, Paul J., et al.. (1994). Identification and quantitation of drugs of abuse in urine using the generalized rank annihilation method of curve resolution. Journal of Chromatography B Biomedical Sciences and Applications. 655(2). 213–223. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact